Cytomegalovirus prophylaxis and treatment after hematopoietic stem cell transplantation in Canada: a description of current practices and comparison with Centers for Disease Control/Infectious Diseases Society of America/American Society for Blood and Marrow Transplantation guideline recommendations
Open Access
- 1 May 2004
- journal article
- research article
- Published by Elsevier in Transplantation and Cellular Therapy
- Vol. 10 (5) , 287-297
- https://doi.org/10.1016/j.bbmt.2003.10.007
Abstract
No abstract availableKeywords
This publication has 46 references indexed in Scilit:
- Transfusion-transmitted cytomegalovirus infection after receipt of leukoreduced blood productsBlood, 2003
- Evaluation of the Murex CMV DNA Hybrid Capture assay (version 2.0) for early diagnosis of cytomegalovirus infection in recipients of an allogeneic stem cell transplantBone Marrow Transplantation, 2001
- Guidelines for preventing opportunistic infections among hematopoietic stem cell transplant recipients: Recommendations of Centers for Disease Control, the Infectious Disease Society of America, and the American Society of Blood and Marrow TransplantationTransplantation and Cellular Therapy, 2000
- A survey of allogeneic bone marrow transplant programs in the United States regarding cytomegalovirus prophylaxis and pre-emptive therapyBone Marrow Transplantation, 2000
- Fatal CMV pneumonia associated with steroid therapy after autologous transplantation in patients previously treated with fludarabineBone Marrow Transplantation, 1998
- PLASMA POLYMERASE CHAIN REACTION FOR CYTOMEGALOVIRUS DNA AFTER ALLOGENEIC MARROW TRANSPLANTATIONTransplantation, 1997
- Cytomegalovirus pp65 Antigenemia after Autologous Marrow and Peripheral Blood Stem Cell TransplantationThe Journal of Infectious Diseases, 1996
- Failure of High-Dose Acyclovir to Prevent Cytomegalovirus Disease after Autologous Marrow TransplantationThe Journal of Infectious Diseases, 1995
- A Randomized, Controlled Trial of Prophylactic Ganciclovir for Cytomegalovirus Pulmonary Infection in Recipients of Allogeneic Bone Marrow TransplantsNew England Journal of Medicine, 1991
- Acyclovir for Prevention of Cytomegalovirus Infection and Disease after Allogeneic Marrow TransplantationNew England Journal of Medicine, 1988